A combinatorial genetic strategy for exploring complex genotype-phenotype associations in cancer

Area of Science:

• Oncology
• Genetics
• Cancer Biology

Background:

• Current genetically defined cancer models lack the complexity and heterogeneity seen in human cancers.
• Existing models often fail to fully represent the diverse genotypic and phenotypic characteristics of human tumors.

Purpose of the Study:

• To rapidly generate diverse and clinically relevant bladder and prostate cancer models.
• To overcome the limitations of current cancer models in capturing human cancer complexity.

Main Methods:

• A combinatorial genetic strategy was employed.
• An organoid transformation assay was utilized for model generation.
• Single-cell and spatially resolved next-generation sequencing were used to analyze tumor architecture.

Main Results:

• Diverse, clinically relevant bladder and prostate cancer models were successfully generated.
• The clonal architecture of the resulting tumors was resolved.
• Polygenic drivers contributing to cancer phenotypes were uncovered.

Conclusions:

• This combinatorial genetic strategy coupled with organoid assays provides a powerful platform for creating complex cancer models.
• Advanced sequencing techniques enable detailed analysis of tumor clonal architecture.
• The findings facilitate the identification of multiple genetic drivers underlying cancer phenotypes, improving our understanding of cancer heterogeneity.